PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3498

  1. 753 Posts.
    lightbulb Created with Sketch. 138
    I'm not convinced that "games" are being played, however, this can only occur if there are minimal buyers for the stock available.
    Put simply, not many are interested in purchasing stock in this company at the moment for a multitude of reasons. The sentiment has been negative for 3 years now.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.